A free CME/CNE/MOC evening symposium • An educational collaboration with
Mount Sinai – National Jewish Health Respiratory Institute and National Jewish Health
Date & Location:
New York, NY – Wednesday, August 14, 2019
The location for this meeting is now full and registration is closed.
Upper Story by Charlie Palmer
979 Third Avenue,14th Floor, New York, NY 10022
Parking: Square Parking, 206 East 59th Street, $11 for up to 6 hours after 4 p.m.
Denver, CO – Wednesday, September 4, 2019
Wellshire Event Center
3333 S. Colorado Blvd., Denver, CO 80222
Parking: There are two lots with ample free parking.
Phoenix, AZ – Thursday, September 5, 2019
2400 E Missouri Ave., Phoenix, AZ 85016
Parking: Valet parking at venue is covered by National Jewish Health
Dallas, TX – Tuesday, November 12, 2019
Hyatt Regency Dallas
300 Reunion Blvd., Dallas, TX 75207
Parking: $6 Self parking at venue
Atlanta, GA – Thursday, November 14, 2019
Westin Atlanta Buckhead
3391 Peachtree Road, N.E, Atlanta, GA 30326
The symposium is from 6:30 p.m. - 8:30 p.m.
Registration/Dinner starts at 6:00 p.m.
Dinner and the syllabus are provided at no charge.
This activity is designed to meet the educational needs of allergists, pulmonologists, primary care physicians, pediatricians, physician assistants, advanced practice nurses and registered nurses who treat patients with asthma.
Upon completion of this activity, the participant will be better able to:
Apply current management guidelines to diagnose asthma correctly, optimize inhaled therapy, address comorbidities, and recognize when asthma is not well controlled.
Review evidence related to potential long-term effects of oral corticosteroids and assess their role in asthma management in the era of biologic therapies.
Identify key features of moderate to severe asthma that are targets for biologic therapies.
Individualize biologic and non-biologic therapies for patients based on their inflammatory phenotype, coexisting conditions, and other individual factors.
Linda Rogers, MD
(Program Co-Chair, presenting in New York, NY and Dallas, TX)
Associate Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine
Director, Clinical Asthma Program
Icahn School of Medicine at Mount Sinai
Mount Sinai – National Jewish Health Respiratory Institute, New York, NY
Michael E. Wechsler, MD, MMSc
(Program Co-Chair, Presenting in Denver, CO and Phoenix, AZ)
Professor of Medicine
Director of the Cohen Family Asthma Institute
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email firstname.lastname@example.org.
You are registered for a meeting ONLY when a red box stating confirmation of registration appears on your screen when you click submit, and then an email confirmation is received in your inbox. If you have questions, please call 800.844.2305.
Accreditation and Designation Statements:
Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Registered Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 2.0 contact hours.
This educational activity is supported by independent educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation.